Viking Thera (VKTX)

$68.86 3.79 (5.82%)

16:00 EDT VKTX Stock Quote Delayed 30 Minutes

VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024

By InvestorPlace Earnings Apr 24, 2024

VKTX stock results show that Viking Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.

3 Biotech Stocks With Skyrocketing Potential: April 2024

3 Red-Hot Biotech Rockets Blasting Off in 2024

3 Stocks With the Potential to Surpass Analyst Expectations for 2024

Volume:

Previous Close -

Market Cap 6.86B

PE Ratio -74.04

EPS -0.93

Volume (Avg. Vol.) 3.53M

Day's Range $62.56 - $69.17

52-Week Range $8.28 - $99.41

Dividend & Yield N/A (N/A)

VKTX Stock Predictions, Articles, and Viking Thera News

From InvestorPlace
From the Web

These 3 Biotech Stocks Are Up 269% in 2024. Is There More to Come?

By Rich Duprey, InvestorPlace Contributor Apr 16, 2024

These three biotech stocks are leading the sector higher on upbeat news but is this as good as it gets or do they have more gas in the tank?

Shed the Fat, Gain the Profits: 3 Weight-Loss Stocks to Own Until 2027

By Chris MacDonald, InvestorPlace Contributor Apr 12, 2024

For investors looking for a way to play weight-loss stocks in this current backdrop, here are three top options to consider right now.

If You Can Only Buy One Biotech Stock in April, It Better Be One of These 3 Names

By Muslim Farooque, InvestorPlace Contributor Apr 11, 2024

Capitalize on the biotech sector's boom with these three top biotech stocks to buy, driven by aging demographics and advanced treatments

Merger Mania: 3 Potential Takeover Targets to Watch for Lucrative Buyouts

By Larry Ramer, InvestorPlace Contributor Apr 2, 2024

With interest rates poised to fall, acquisitions will become more numerous. Here are three potential takeover targets.

The 3 Best Biotech Stocks to Buy in April 2024

By Ian Cooper, InvestorPlace Contributor Apr 1, 2024

Biotech is one of the hottest sectors on the market, creating big opportunities for some of the best biotech stocks to buy in April.

The 3 Best Russell 2000 Stocks to Buy in Q2 2024

By Joel Lim, InvestorPlace Contributor Mar 30, 2024

Find out about the three best small-cap stocks in the best Russell 2000 to buy this upcoming quarter for significant returns.

Why Is Viking Therapeutics (VKTX) Stock Up 24% Today?

By William White, InvestorPlace Writer Mar 26, 2024

Viking Therapeutics stock is rising higher on Tuesday as investors in VNKTX shares react to positive Phase 1 clinical trial results.

7 Biotech Stocks to Buy as Sector Rotation Ramps Up

By Josh Enomoto, InvestorPlace Contributor Mar 13, 2024

While the technology sector has been enjoying ridiculous returns, it’s inevitable that a slowdown (or even a correction) may materialize, which brings to the table…

3 Stock Winners That Are Up 1,000% or More in 2024

By Ian Cooper, InvestorPlace Contributor Mar 8, 2024

Dig deep enough, and find a story hot enough, and you can uncover potential stock winners up 1,000%. Here are three.

3 Biotech Stocks Bound to Blast Off By 2029

By Chandler Capital, InvestorPlace Contributor Feb 27, 2024

Biotech stocks are risky, but rewarding. These three biotechs specifically could see exponential gains in the coming years.

Why Is Viking Therapeutics (VKTX) Stock Up 96% Today?

By William White, InvestorPlace Writer Feb 27, 2024

Viking Therapeutics stock is up on Tuesday with heavy trading of VKTX shares after the company reported positive Phase 2 trial results!

The 3 Biotech Stocks That Could Make Your February Unforgettable

By Ian Cooper, InvestorPlace Contributor Feb 15, 2024

After a blistering hot year of biotech M&A, we’ll see more of the same in 2024. That could be great news for these hot biotech stocks.

7 Must-Buy Pharma Stocks Amid the Weight Loss Drug Revolution

By Alex Sirois, InvestorPlace Contributor Feb 14, 2024

Obesity drug sales boomed in 2023 and will continue in 2024 making these weight loss stocks attratcive considerations for pharma investors.

The 3 Most Undervalued Biotech Stocks to Buy in February 2024

By Ian Cooper, InvestorPlace Contributor Feb 8, 2024

With patience, some of the most undervalued biotech stocks can create massive wealth, such as these three to consider.

The 3 Best Biotech Stocks to Invest in for Big Gains in 2024

By Muslim Farooque, InvestorPlace Contributor Feb 2, 2024

These pivotal biotech stocks for gains are charting the future of medicine and investment growth in 2024 offering powerful returns

3 Biotech Stocks to Turn $10,000 Into $1 Million: January 2024

By Ian Cooper, InvestorPlace Contributor Jan 22, 2024

Biotech stocks are some of the most exciting opportunities on the market. Find the right ones with catalysts, and you could make a fortune.

The 3 Best Biotech Stocks to Buy in January 2024

By Ian Cooper, InvestorPlace Contributor Jan 9, 2024

Biotech is still one of the most exciting investments on the market, creating substantial opportunities for some of the best biotech stocks.

M&A Watch: 3 Drug Maker Stocks That Could Be Acquired in 2024

By Larry Ramer, InvestorPlace Contributor Jan 2, 2024

Two factors --lower interest rates and the low valuation of many biotech stocks -- are likely to result in many biotech companies being acquired in…

Why Is Viking Therapeutics (VKTX) Stock Moving Today?

By William White, InvestorPlace Writer Oct 18, 2023

Viking Therapeutics stock is on the move Wednesday as investors react to results from the company's latest clinical trial!

The 7 Most Undervalued Healthcare Stocks to Buy Now: August 2023

By Alex Sirois, InvestorPlace Contributor Aug 16, 2023

All of these healthcare stocks to buy are underpriced and relatively stable investments over the mid-to-long term.

Viking Thera (VKTX)

VKTX Stock Earnings: Viking Therapeutics Beats EPS for Q1 2024

3 Biotech Stocks With Skyrocketing Potential: April 2024

3 Red-Hot Biotech Rockets Blasting Off in 2024

3 Stocks With the Potential to Surpass Analyst Expectations for 2024

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Viking Thera (VKTX)

Top 5 Stocks for 2024

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

VKTX Stock Predictions, Articles, and Viking Thera News

Subscriber Sign in